OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
Alessandro Ottaiano, Monica Ianniello, Mariachiara Santorsola, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1183-1183
Open Access | Times Cited: 18

Showing 18 citing articles:

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9

Diagnostic performance of radiomics in prediction of Ki-67 index status in non-small cell lung cancer: A systematic review and meta-analysis
Ramin Shahidi, Ehsan Hassannejad, Mansoureh Baradaran, et al.
Journal of medical imaging and radiation sciences (2024) Vol. 55, Iss. 4, pp. 101746-101746
Closed Access | Times Cited: 4

Potential therapeutic applications of medical gases in cancer treatment
Abbas Al Bazzal, Bassel H. Hoteit, Mariam Chokor, et al.
Medical Gas Research (2025) Vol. 15, Iss. 2, pp. 309-317
Closed Access

Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells
Mahmoud Singer, Jennifer Valerin, Zhuoli Zhang, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 166-166
Open Access

Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis
Federica Malighetti, Matteo Villa, A. Villa, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1943-1943
Open Access

Extracellular vesicle-mediated chemoresistance in breast cancer: focus on miRNA cargo
Maria Chiara Ciferri, Roberta Tasso
Extracellular Vesicles and Circulating Nucleic Acids (2025) Vol. 6, Iss. 1, pp. 112-27
Open Access

The role of Prolyl 3-Hydroxylase 1 (P3H1) in tumor development and prognosis: a pan-cancer analysis with validation in colonic adenocarcinoma
Yanqin Chen, Moazzam Ali, Muhammad Tayyab, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 770-790
Closed Access

Principles and therapeutics of cancer
Yoontae Lee
Molecules and Cells (2025), pp. 100201-100201
Open Access

Oncogenic KRASG12D Transfer from Platelet-like Particles Enhances Proliferation and Survival in Non-Small Cell Lung Cancer Cells
Jorge Ceron, Gonzalo Martínez-Navajas, Jose Manuel Sanchez-Manas, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3264-3264
Open Access

Precision medicine in breast cancer (Review)
Petros Papalexis, Vasiliki Georgakopoulou, Panagiotis Drossos, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 5
Open Access | Times Cited: 3

Engineered extracellular vesicles for cancer drug delivery and therapeutics
Marina Pérez-Capó, Antònia Obrador‐Hevia, Diego Pérez, et al.
Current Opinion in Physiology (2024) Vol. 39, pp. 100755-100755
Closed Access | Times Cited: 1

High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients
Annabella Di Mauro, Mariachiara Santorsola, Giovanni Savarese, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Diagnostic Performance of Radiomics in Prediction of Ki-67 Index Status in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Ramin Shahidi, Ehsan Hassannejad, Mansoureh Baradaran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Special Issue “Cancer Biomarker Research and Personalized Medicine 2.0”
James Meehan, Mark Gray
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 549-549
Open Access

Tumor heterogeneity and its impact on sotorasib response in a patient with non-small cell lung cancer
Karolina P. Nalewaj, Izabela Chmielewska, Paweł Krawczyk, et al.
Oncology in Clinical Practice (2023) Vol. 20, Iss. 5, pp. 351-358
Open Access

Page 1

Scroll to top